[St. John' Wort (Hypericum perforatum L.)--multicompound preparations versus single substances]. 2003

J Reichling, and K Hostanska, and R Saller
Institut für Pharmazie und Molekulare Biotechnologie, Abt. Biologie, Universität Heidelberg, Germany. juergen.reichling@urz.uni-heidelberg.de

Aqueous alcoholic extracts of St. John s wort are used for the treatment of mild to moderate depression. Recently, Hypericum extracts were also shown to inhibit the growth of various human malignant cells. We promote the hypothesis that the various biological activities of aqueous Hypericum extracts are based on synergistic interactions of all compounds present therein and not on the pharmacological activities of single compounds.

UI MeSH Term Description Entries
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D020902 Hypericum Genus of perennial plants in the family CLUSIACEAE (sometimes classified as Hypericaceae). Herbal and homeopathic preparations are used for depression, neuralgias, and a variety of other conditions. Hypericum contains flavonoids; GLYCOSIDES; mucilage, TANNINS; volatile oils (OILS, ESSENTIAL), hypericin and hyperforin. Hypericum perforatum,Saint Johns Wort,St. Johns Wort,Saint John's Wort,Saint Johnswort,St. John's Wort,St. Johnswort,Hypericum perforatums,Hypericums,John's Wort, Saint,John's Wort, St.,Johns Wort, Saint,Johns Wort, St.,Johnswort, Saint,Johnswort, St.,Saint John Wort,St. John Wort,Wort, Saint John's,Wort, Saint Johns,Wort, St. John's,Wort, St. Johns,perforatums, Hypericum

Related Publications

J Reichling, and K Hostanska, and R Saller
March 2009, Journal of primary health care,
J Reichling, and K Hostanska, and R Saller
February 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
J Reichling, and K Hostanska, and R Saller
November 1950, Die Pharmazie,
J Reichling, and K Hostanska, and R Saller
December 2000, Praxis,
J Reichling, and K Hostanska, and R Saller
March 2000, The Medical journal of Australia,
J Reichling, and K Hostanska, and R Saller
February 2000, Lancet (London, England),
J Reichling, and K Hostanska, and R Saller
February 2000, Lancet (London, England),
J Reichling, and K Hostanska, and R Saller
February 2000, Lancet (London, England),
J Reichling, and K Hostanska, and R Saller
February 2000, Lancet (London, England),
J Reichling, and K Hostanska, and R Saller
September 2011, Molecules (Basel, Switzerland),
Copied contents to your clipboard!